0001209191-17-040171.txt : 20170615
0001209191-17-040171.hdr.sgml : 20170615
20170615165354
ACCESSION NUMBER: 0001209191-17-040171
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170613
FILED AS OF DATE: 20170615
DATE AS OF CHANGE: 20170615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000831547
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930979187
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
BUSINESS PHONE: 702-835-6300
MAIL ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
FORMER COMPANY:
FORMER CONFORMED NAME: NEOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19960819
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICUS FUNDING CORP
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krassner Stuart Mitchell
CENTRAL INDEX KEY: 0001311636
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35006
FILM NUMBER: 17914017
MAIL ADDRESS:
STREET 1: 157 TEHCNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-13
0
0000831547
SPECTRUM PHARMACEUTICALS INC
SPPI
0001311636
Krassner Stuart Mitchell
11500 S. EASTERN AVENUE
SUITE 240
HENDERSON
NV
89052
1
0
0
0
Common Stock, $0.001 par value
2017-06-13
4
F
0
3523
6.48
D
43324
D
Common Stock, $0.001 par value
2017-06-13
4
A
0
10000
0.00
A
53324
D
Stock Option (Right to Buy)
6.48
2017-06-13
4
A
0
20000
0.00
A
2027-06-13
Common Stock
20000
20000
D
Represents shares withheld by Spectrum to satisfy the Reporting Person's tax withholding obligations. The shares have not been sold by the Reporting Person or by Spectrum. The shares have been cancelled by the transfer agent.
100% of the restricted shares shall vest on the earlier of (1) June 13, 2018 or (2) the date of the company's 2018 Annual Meeting of Shareholders.
25% of the option shares vested on June 13, 2017. The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years.
/s/ Kurt A. Gustafson, attorney-in-fact for Stuart M. Krassner
2017-06-15